| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Other non-current liabilities | 90 | - |
| Net cash used in operating activities | -43,003 | -30,087 |
| Purchases of property and equipment | 150 | 59 |
| Payment of security deposits | 126 | 131 |
| Net cash used in investing activities | -276 | -190 |
| Issuance of common stock and warrants, net | 18,326 | - |
| Payment of eb-5 loan | 1,000 | 1,000 |
| Payments from issuance of common stock, net | - | 184 |
| Net cash provided by financing activities | 17,326 | -1,184 |
| Effect of changes in exchange rate on cash and restricted cash | 10 | -36 |
| Net decrease in cash and restricted cash | -25,943 | -31,497 |
| Cash and cash equivalents at beginning of period | 58,821 | - |
| Cash and cash equivalents at end of period | 32,879 | - |
Ocugen, Inc. (OCGN)
Ocugen, Inc. (OCGN)